Medlive Technology Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
369.00
279.00
157.00
84.00
117.00
41.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-30.00
24.00
-11.00
-33.00
20.00
-15.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
295.00
281.00
140.00
58.00
124.00
31.00
Cash Flow from Investing Activities
-58.00
-870.00
-4,220.00
-66.00
0.00
-2.00
Cash Flow from Financing Activities
-214.00
-147.00
-26.00
4,570.00
-3.00
-3.00
Net Cash Inflow / Outflow
85.00
-666.00
-3,722.00
4,497.00
121.00
25.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
62.00
69.00
383.00
-65.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Medlive Technology Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
369.15002855284
709.534514340196
-340.00
-47.97%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-30.979527851878
97.9422765887916
-127.00
-131.63%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
295.973592974533
1447.32715468758
-1,152.00
-79.55%
Cash Flow from Investing Activities
-58.1642722549905
-696.885958993539
638.00
91.65%
Cash Flow from Financing Activities
-214.553803521666
-819.494327999306
605.00
73.82%
Net Cash Inflow / Outflow
85.7415056890897
-52.5306451693377
137.00
263.22%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
62.485988491213
16.5224871359244
46.00
278.19%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 5.01% vs 100.81% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
295.97
281.86
5.01%






